Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-05

Clinical Trial Update: The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Dexloxiglumide for functional dyspepsia has completed. The update presents the study results regarding safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexloxiglumide (Dexloxiglumide)

Snippet

Sponsor: Forest Laboratories | Conditions: Dyspepsia | Phase 2 | Status: COMPLETED